Eli Lilly and Company has developed an app for people living with Type II diabetes who use Trulicity, the company’s once-per-week injectable diabetes medication that also works with a click-activated ...
Medically reviewed by Mary Choy, PharmD Key Takeaways Mounjaro often leads to greater reductions in hemoglobin A1C and weight compared to similar medications.Trulicity can help reduce major ...
The US Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company's Trulicity (dulaglutide). The approval expands the label of once-weekly Trulicity to include 3.0 mg ...
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C and weight In the trial, Mounjaro was associated ...